Episode 185: resistant HTN tx, mirtazepine for sleep, baloxav for prevention, PRP for OA episode artwork

EPISODE · Jul 16, 2025 · 32 MIN

Episode 185: resistant HTN tx, mirtazepine for sleep, baloxav for prevention, PRP for OA

from Primary Care Update · host Mark Ebell

This week our intrepid primary care docs discuss 4 new POEMs: spironolactone vs amiloride for resistant hypertension, mirtazapine for insomnia in older adults, baloxivir for influenza post exposure prophylaxis, and platelet-rich plasma injections for knee osteoarthritis. We've got opinions!Show notes:Spironolactone vs amiloride for resistant hypertension: pubmed.ncbi.nlm.nih.gov/40366680/ Mirtazapine for chronic insomnia: https://pubmed.ncbi.nlm.nih.gov/40135470/ Baloxavir to prevent flu in household contacts: https://pubmed.ncbi.nlm.nih.gov/40267424/ Platelet-rich plasma for knee OA: https://pubmed.ncbi.nlm.nih.gov/39751394/

Episode metadata supplied by the publisher feed · Published Jul 16, 2025

Embed this episode

NOW PLAYING

Episode 185: resistant HTN tx, mirtazepine for sleep, baloxav for prevention, PRP for OA

0:00 32:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Primary Care Update?

This episode is 32 minutes long.

When was this Primary Care Update episode published?

This episode was published on July 16, 2025.

Can I download this Primary Care Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!